NephroGenex

November 4, 2019

Share this entry

Share on Facebook
Share on WhatsApp
Share on LinkedIn
Share by Mail

http://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.png 0 0 roaradmin http://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.png roaradmin2019-11-04 17:11:062019-11-04 17:11:06NephroGenex

In the News

Cassel Salpeter & Co. Facilitates Sale of Bird Global Inc. Assets to Third Lane Mobility Inc. For $145 Million in Micromobility Firm’s Chapter 11 BankruptcyApril 11, 2024 - 7:38 pm
Flying cars are coming! Here’s how they could change the way you travel.April 9, 2024 - 8:20 pm
QEP Completes Sale Of Australia/New Zealand BusinessMarch 4, 2024 - 1:30 pm
QEP Agrees To Sell Australia/New Zealand BusinessFebruary 20, 2024 - 8:25 pm
Add-On Deals Will Drive 2024 Middle Market M&AJanuary 15, 2024 - 9:13 pm

Cassel Salpeter & Co. is an Independent Investment banking firm that provides advice to middle-market and emerging growth companies.

Quick Links

Team
About
Services
Industries
News
Contact

Get In Touch

Cassel Salpeter & Co.
801 Brickell Avenue,
Suite 1900
Miami, FL 33131
(305) 438-7700

Quick Links

Get In Touch

Stay Informed